ATE214427T1 - Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän - Google Patents

Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän

Info

Publication number
ATE214427T1
ATE214427T1 AT96913930T AT96913930T ATE214427T1 AT E214427 T1 ATE214427 T1 AT E214427T1 AT 96913930 T AT96913930 T AT 96913930T AT 96913930 T AT96913930 T AT 96913930T AT E214427 T1 ATE214427 T1 AT E214427T1
Authority
AT
Austria
Prior art keywords
chimeric
msp
daf
localizing domain
tell
Prior art date
Application number
AT96913930T
Other languages
English (en)
Inventor
Michael A Innis
Isabel Zaror
Abla A Creasey
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE214427T1 publication Critical patent/ATE214427T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96913930T 1995-05-05 1996-05-03 Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän ATE214427T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/435,149 US5866402A (en) 1995-05-05 1995-05-05 Chimeric MCP and DAF proteins with cell surface localizing domain
PCT/US1996/006301 WO1996034965A2 (en) 1995-05-05 1996-05-03 Chimeric mcp and daf proteins with cell surface localizing domain

Publications (1)

Publication Number Publication Date
ATE214427T1 true ATE214427T1 (de) 2002-03-15

Family

ID=23727198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913930T ATE214427T1 (de) 1995-05-05 1996-05-03 Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän

Country Status (8)

Country Link
US (1) US5866402A (de)
EP (1) EP0826058B1 (de)
JP (2) JP3862753B2 (de)
AT (1) ATE214427T1 (de)
AU (1) AU708102B2 (de)
CA (1) CA2218129C (de)
DE (1) DE69619808T2 (de)
WO (1) WO1996034965A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9800817D0 (en) * 1998-01-16 1998-03-11 Bio Discovery Ltd Serine protease inhibitors
JP5232350B2 (ja) * 2001-04-17 2013-07-10 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー Ｃａ１２５遺伝子のリピート配列並びに診断および治療的介入のためのその使用
ATE496134T1 (de) 2002-03-29 2011-02-15 Xoma Technology Ltd Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
AT412785B (de) 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
US8124097B2 (en) 2004-01-21 2012-02-28 Case Western Reserve University Hybrid and chimeric polypeptides that regulate activation of complement
US20080090760A2 (en) * 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US8877896B2 (en) * 2008-02-15 2014-11-04 Tufts University Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
JP6202669B2 (ja) * 2013-04-26 2017-09-27 国立研究開発法人国立循環器病研究センター ペプチド及びその複合体、組織修復用スキャフォールド及びその表面処理方法、並びに表面処理液又は処理液のセット
US20220195012A1 (en) * 2019-04-13 2022-06-23 National Centre For Cell Science Daf-mcp chimeric proteins, process to manufacture the same and use of the chimeric protein for treating pathological conditions involving the complement system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294551A (en) * 1987-08-25 1994-03-15 Regents Of The University Of Minnesota Cell culture substrate coated with polypeptides having fibronectin activity
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
EP0537171B1 (de) * 1990-05-11 2002-09-18 The Austin Research Institute CD46 Isoformen
AU8947791A (en) * 1990-11-01 1992-05-26 Scripps Research Institute, The Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
EP0512733A2 (de) * 1991-05-03 1992-11-11 Washington University Modifizierter Komplementsystemregler
US5679546A (en) * 1993-09-24 1997-10-21 Cytomed, Inc. Chimeric proteins which block complement activation

Also Published As

Publication number Publication date
US5866402A (en) 1999-02-02
AU5674996A (en) 1996-11-21
WO1996034965A3 (en) 1997-01-03
AU708102B2 (en) 1999-07-29
EP0826058B1 (de) 2002-03-13
JP3862753B2 (ja) 2006-12-27
JP2006117696A (ja) 2006-05-11
WO1996034965A2 (en) 1996-11-07
DE69619808D1 (de) 2002-04-25
JPH11511117A (ja) 1999-09-28
DE69619808T2 (de) 2002-11-21
CA2218129A1 (en) 1996-11-07
CA2218129C (en) 2009-10-06
EP0826058A2 (de) 1998-03-04

Similar Documents

Publication Publication Date Title
ZA967173B (en) Purified coprinus laccases and nucleic acids and encoding same
EP0777678A4 (de)
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
CA2315274A1 (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU2827895A (en) Purified polyporus laccases and nucleic acids encoding same
AU2656695A (en) Purified scytalidium laccases and nucleic acids encoding same
CY1109978T1 (el) Αντιγονικα πεπτιδια εξαγομενα απο τελομεραση
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
ES2145015T3 (es) Proteasas especificas de ubiquitina.
IL193886A (en) Antibodies that bind to ldcam sequences
AU3802595A (en) Tripeptidyl aminopeptidase
DE60142646D1 (en) Fusionprotein
ATE214427T1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
AU6724794A (en) GRB3-3 gene, its variants and their uses
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
AU3711597A (en) A novel galanin receptor
IL139604A0 (en) Novel peptides
AU1935399A (en) Nucleotide and protein sequence of mammastatin and methods of use
IL147810A0 (en) Antitumor antibodies, proteins and uses thereof
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU1526099A (en) Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
AU1099697A (en) Novel xylanases, genes encoding them, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties